Restoring tumor-suppressive miRNAs like miR-145 and miR-138 or blocking oncogenic miRNAs like miR-21 can alter actin-binding proteins like cofilin 1 and ezrin, which will alter cytoskeletal dynamics and lessen invasiveness [48,74,75]. The gene discussed is CFL1; the disease is neoplasm.